| ERCC1 isoform expression and DNA repair in non–small-cell lung cancer L Friboulet, KA Olaussen, JP Pignon, FA Shepherd, MS Tsao, S Graziano, ... New England Journal of Medicine 368 (12), 1101-1110, 2013 | 428 | 2013 |
| Pooled Analysis of the Prognostic and Predictive Effects of KRAS Mutation Status and KRAS Mutation Subtype in Early-Stage Resected Non–Small-Cell Lung … FA Shepherd, C Domerg, P Hainaut, PA Jänne, JP Pignon, S Graziano, ... Journal of clinical oncology 31 (17), 2173-2181, 2013 | 363 | 2013 |
| Prognostic effect of tumor lymphocytic infiltration in resectable non–small-cell lung cancer E Brambilla, G Le Teuff, S Marguet, S Lantuejoul, A Dunant, S Graziano, ... Journal of clinical oncology 34 (11), 1223, 2016 | 328 | 2016 |
| Subtype classification of lung adenocarcinoma predicts benefit from adjuvant chemotherapy in patients undergoing complete resection MS Tsao, S Marguet, G Le Teuff, S Lantuejoul, FA Shepherd, L Seymour, ... Journal of clinical oncology 33 (30), 3439, 2015 | 285 | 2015 |
| Mesenchymal transition and PDGFRA amplification/mutation are key distinct oncogenic events in pediatric diffuse intrinsic pontine gliomas S Puget, C Philippe, DA Bax, B Job, P Varlet, MP Junier, F Andreiuolo, ... PloS one 7 (2), e30313, 2012 | 261 | 2012 |
| Tumor mutation burden as a biomarker in resected non–small-cell lung cancer S Devarakonda, F Rotolo, MS Tsao, I Lanc, E Brambilla, A Masood, ... Journal of Clinical Oncology 36 (30), 2995, 2018 | 232 | 2018 |
| Anti‐hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIV‐infected patients Y Benhamou, H Fleury, P Trimoulet, I Pellegrin, R Urbinelli, C Katlama, ... Hepatology 43 (3), 548-555, 2006 | 221 | 2006 |
| Cyclophosphamide compared with ifosfamide in consolidation treatment of standard-risk Ewing sarcoma: results of the randomized noninferiority Euro-EWING99-R1 trial MC Le Deley, M Paulussen, I Lewis, B Brennan, A Ranft, J Whelan, ... J Clin Oncol 32 (23), 2440-8, 2014 | 186 | 2014 |
| Prediction of fluid responsiveness by a continuous non-invasive assessment of arterial pressure in critically ill patients: comparison with four other dynamic indices X Monnet, M Dres, A Ferré, G Le Teuff, M Jozwiak, A Bleibtreu, ... British journal of anaesthesia 109 (3), 330-338, 2012 | 156 | 2012 |
| High-dose chemotherapy and blood autologous stem-cell rescue compared with standard chemotherapy in localized high-risk Ewing sarcoma: results of Euro-EWING 99 and Ewing-2008 J Whelan, MC Le Deley, U Dirksen, G Le Teuff, B Brennan, N Gaspar, ... Journal of Clinical Oncology 36 (31), 3110-3119, 2018 | 150 | 2018 |
| Renal cell carcinoma programmed death-ligand 1, a new direct target of hypoxia-inducible factor-2 alpha, is regulated by von Hippel–Lindau gene mutation status Y Messai, S Gad, MZ Noman, G Le Teuff, S Couve, B Janji, SF Kammerer, ... European urology 70 (4), 623-632, 2016 | 141 | 2016 |
| PD-L1 protein expression assessed by immunohistochemistry is neither prognostic nor predictive of benefit from adjuvant chemotherapy in resected non-small cell lung cancer MS Tsao, G Le Teuff, FA Shepherd, C Landais, P Hainaut, M Filipits, ... Annals of Oncology 28 (4), 882-889, 2017 | 125 | 2017 |
| Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriers M Muller, S Ferlicot, M Guillaud‐Bataille, G Le Teuff, C Genestie, ... Clinical genetics 92 (6), 606-615, 2017 | 121 | 2017 |
| Myocardial injury in critically ill patients: relation to increased cardiac troponin I and hospital mortality JP Quenot, G Le Teuff, C Quantin, JM Doise, M Abrahamowicz, D Masson, ... Chest 128 (4), 2758-2764, 2005 | 115 | 2005 |
| Pooled analysis of the prognostic and predictive effects of TP53 comutation status combined with KRAS or EGFR mutation in early-stage resected non–small-cell lung cancer in … FA Shepherd, B Lacas, G Le Teuff, P Hainaut, PA Jänne, JP Pignon, ... Journal of Clinical Oncology 35 (18), 2018, 2017 | 110 | 2017 |
| Expression of miR-487b and miR-410 encoded by 14q32. 31 locus is a prognostic marker in neuroblastoma CH Gattolliat, L Thomas, SA Ciafre, G Meurice, G Le Teuff, B Job, ... British journal of cancer 105 (9), 1352-1361, 2011 | 110 | 2011 |
| Hypertension and angiotensin system inhibitors: impact on outcome in sunitinib-treated patients for metastatic renal cell carcinoma H Izzedine, L Derosa, G Le Teuff, L Albiges, B Escudier Annals of Oncology 26 (6), 1128-1133, 2015 | 108 | 2015 |
| High-dose chemotherapy compared with standard chemotherapy and lung radiation in Ewing sarcoma with pulmonary metastases: results of the European Ewing Tumour Working … U Dirksen, B Brennan, MC Le Deley, N Cozic, H Van Den Berg, V Bhadri, ... Journal of clinical oncology 37 (34), 3192-3202, 2019 | 98 | 2019 |
| Assessment of potential drug interactions in patients with epilepsy: impact of age and sex BE Gidal, JA French, P Grossman, G Le Teuff Neurology 72 (5), 419-425, 2009 | 90 | 2009 |
| Prognostic and predictive effect of TP53 mutations in patients with non–small cell lung cancer from adjuvant cisplatin–based therapy randomized trials: A LACE-bio pooled analysis X Ma, G Le Teuff, B Lacas, MS Tsao, S Graziano, JP Pignon, JY Douillard, ... Journal of Thoracic Oncology 11 (6), 850-861, 2016 | 87 | 2016 |
